Link
A recent data release offers new ways to access data from the Count Me In project. The nonprofit research initiative enables patients in the US and Canada to share their medical information and samples for cancer research. Notably, Count Me In has been able to sequence and share data from patients with very rare or understudied cancers such as angiosarcoma.
Users may browse mutations from angiosarcoma (33 patients), metastatic breast cancer (200) and metastatic prostate cancer (30) directly in the GDC data portal. Available data includes whole exome and RNA sequencing data, mutations, and splice junction quantifications. Aliquot-level MAF mutation files are also available.
Also in the latest data release, find additional cases from NCI's Human Cancer Model Initiative (HCMI) and Clinical Proteomic Tumor Analysis Consortium (CPTAC) programs. Microsatellite instability (MSI) status is a new search feature in the data portal.